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A Commentary on    
 
Cairo F, Barbato L, Selvaggi F, Baielli MG, Piattelli A, Chambrone L. Surgical 
procedures for soft tissue augmentation at implant sites. A systematic review and meta-
analysis of randomized controlled trials. Clin Implant Dent Relat Res. 2019; 21(6):1262-
1270. 
 
Data sources: PubMed, The Cochrane Oral Health Group Trials Register and 
EMBASE. 
 
Additionally, issues of the following journals between 2000-April 2019 were hand 
searched: Journal of Clinical Periodontology, Journal of Periodontology, International 
Journal of Periodontology and Restorative Dentistry, European Journal of Oral 
Implantology, Journal of Oral Maxillofacial Surgery, Clinical Implant Dentistry and 
Related Research, and Clinical Oral Implants Research 
 
Study selection:  Only randomised controlled trials (RCTs) involving soft tissue 
augmentation at dental implant sites were considered for inclusion. The selection was 
restricted to RCTs published in English language with at least 10 patients per group and 
a minimum follow-up period of 3 months. A PICO method was used to organise the 
inclusion criteria and soft tissue augmentations were clustered into three groups i.e., 
before prosthetic treatment, after prosthetic treatment and at immediate implant 
placement.   
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Data extraction and synthesis: The screening of titles and abstracts was carried out by 
two reviewers and disagreements were moderated by a third reviewer. Eligibility was 
determined using full texts and data were extracted using purposefully designed forms. 
The Cochrane Handbook of Systematic Reviews of Interventions toolkit was used to 
assess the risk of bias. The studies were grouped according to the type of intervention 
and subjected to quantitative data synthesis. Continuous outcome measures were 
assessed using random-effects meta-analyses and pooled estimates were expressed as 
weighted mean differences (MD) along with 95% confidence intervals (CI).  
 
Results: Following initial electronic and hand searches, 2119 studies were screened for 
title and abstract and 32 studies were considered for full text screening. Only 14 RCTs 
met the inclusion criteria and the remaining 18 studies were excluded from the 
systematic review. The included studies described soft tissue augmentation for 538 
implants placed in 475 patients.  Three studies (68 patients; 78 implants) reported 
improved soft tissue thickness with xenogenic collagen matrix (XCM) augmentation 
compared to no augmentation at the implant sites before prosthetic treatment (high 
/unclear risk of bias). One study (28 patients; 41 implants) reported improved height of 
keratinised tissue (KT) ) and marginal bone levels (MBL) with free gingival graft (FGG) 
compared to no augmentation at the implant sites after prosthetic treatment (unclear risk 
of bias). Three RCTs (126 patients; 126 implants) focused on connective tissue grafting 
(CTT) and bone grafting  vs no grafting in conjunction with immediate implant placement 
after tooth extraction (unclear risk of bias). There was no difference in MBL in any of the 
studies while one study showed superior soft tissue thickness (STT). Four RCTs (129 
patients; 133 implants) compared different augmentation techniques before prosthetic 
treatment. Only one study showed improved STT with CTG compared to XCM (low risk 
of bias). Finally, three RCTs (124 patients; 160 implants) compared different 
augmentation techniques after prosthetic treatment (High/ unclear risk of bias). FGG was 
observed to be superior to acellular dermal matrix (ADM) and vestibuloplasty to improve 
KT. Meta analyses showed did not favour CTT to improve MBL at extraction sites but 
CTT was superior to XCM to improve STT before prosthetic treatment.  
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Conclusions   
Notwithstanding the limitations of the systematic review, soft tissue augmentation 
significantly enhances the amount of soft tissue at the implant site. CTG at the extraction 
site also improves subsequent bone level of the implants. Moreover, CTG prior to 
prosthetic treatment  is superior to XCM to improve thickness of peri-implant soft tissues. 
However, these findings are based on short-term follow-up and future studies with 
improved methodology are required to establish the long-term benefits of soft tissue 
augmentation at the dental implant sites.  
GRADE Rating:  Medium  
Commentary  
The systematic review and meta-analysis by Cairo et al., 2019 presents a 
comprehensive review of the potential benefits of soft tissue augmentation at dental 
implant sites. Improved soft tissue thickness around dental implants has been shown to 
reduce the risk of peri-implantitis and may also contribute to improved aesthetics and 
patient satisfaction.   
 
Peri-implantitis is a topical issue in modern dental implantology practice as it is one of 
the commonest and most recognised complication associated with dental implants.1,2  
Peri-implantitis is a plaque-associated pathological condition occurring in tissues around 
dental implants, characterized by inflammation in the peri-implant mucosa and 
subsequent progressive loss of supporting bone and implant failure.3,4 Various 
conservative measures and surgical interventions are reported to aid in the management 
of established peri-implantitis.5 However, primary prevention of this complication remains 
the ideal goal.6  This systematic review underscores the emerging evidence to support 
the use of soft tissue augmentation at implant sites to facilitate gain of keratinised 
mucosa and thereby improve peri-implant health and aesthetics.   
 
Although this systematic review strengthens the existing evidence to support the use of 
soft tissue augmentation for dental implants, heterogeneity in the design of RCTs and 
risk of bias were identified as major impediments to synthesis of results. Some minor 
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typographic errors were noted in the manuscript, but these did not appear to affect the 
accuracy of the review.  
 
RCTs remain a primary source of evidence in clinical practice and are invariably 
resource-intensive, time consuming and expensive. Therefore, it seems sensible to 
develop tailored guidelines for conducting future RCTs on dental implants. These 
guidelines should be aimed at minimizing variations in measurement of outcomes (such 
as, implant stability, peri-implant soft tissue health) as well as reducing the risks of bias 
in implant studies.  Lastly, patient-reported outcome measures (PROMs)  are now 
recognised as an important component of clinical research.7 However, it appears that 
PROMS are used less frequently in dental implant research. Future research on dental 
implants may benefit from incorporating PROMS in the research design more 




Practice Points   
 
1. Soft tissue augmentation improves the amount of keratinised mucosa around 
dental implants and may serve to improve aesthetics and reduce the risk of peri-
implantitis 
 
2. Consideration should be given to incorporate soft tissue augmentation of dental 
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